Los Angeles Capital Management LLC Has $19.61 Million Stock Holdings in The Cigna Group (NYSE:CI)

Los Angeles Capital Management LLC lifted its position in shares of The Cigna Group (NYSE:CI) by 137.3% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 65,490 shares of the health services provider’s stock after buying an additional 37,889 shares during the quarter. Los Angeles Capital Management LLC’s holdings in The Cigna Group were worth $19,611,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Eads & Heald Wealth Management raised its holdings in shares of The Cigna Group by 1.7% in the 3rd quarter. Eads & Heald Wealth Management now owns 2,123 shares of the health services provider’s stock valued at $607,000 after acquiring an additional 35 shares in the last quarter. Relyea Zuckerberg Hanson LLC increased its holdings in shares of The Cigna Group by 3.2% in the 4th quarter. Relyea Zuckerberg Hanson LLC now owns 1,113 shares of the health services provider’s stock worth $333,000 after buying an additional 35 shares during the last quarter. E&G Advisors LP raised its position in shares of The Cigna Group by 1.8% during the 3rd quarter. E&G Advisors LP now owns 2,137 shares of the health services provider’s stock valued at $611,000 after buying an additional 37 shares in the last quarter. Sequoia Financial Advisors LLC raised its position in shares of The Cigna Group by 1.4% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 2,822 shares of the health services provider’s stock valued at $807,000 after buying an additional 39 shares in the last quarter. Finally, Breakwater Capital Group lifted its holdings in shares of The Cigna Group by 3.5% during the 4th quarter. Breakwater Capital Group now owns 1,144 shares of the health services provider’s stock worth $349,000 after acquiring an additional 39 shares during the last quarter. 86.99% of the stock is owned by institutional investors.

The Cigna Group Stock Down 0.9 %

Shares of NYSE CI traded down $3.00 during mid-day trading on Friday, hitting $341.50. 2,413,548 shares of the stock traded hands, compared to its average volume of 1,380,653. The company has a market cap of $99.84 billion, a price-to-earnings ratio of 28.03, a PEG ratio of 1.05 and a beta of 0.57. The stock has a fifty day moving average price of $350.82 and a 200-day moving average price of $319.39. The Cigna Group has a 52 week low of $240.50 and a 52 week high of $365.71. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.67 and a current ratio of 0.71.

The Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, May 2nd. The health services provider reported $6.47 EPS for the quarter, beating analysts’ consensus estimates of $6.17 by $0.30. The Cigna Group had a net margin of 1.76% and a return on equity of 17.24%. The firm had revenue of $57.25 billion for the quarter, compared to analysts’ expectations of $56.59 billion. During the same quarter in the prior year, the company posted $5.41 earnings per share. The business’s revenue for the quarter was up 23.2% on a year-over-year basis. Research analysts anticipate that The Cigna Group will post 28.4 EPS for the current year.

The Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 20th. Investors of record on Tuesday, June 4th will be issued a $1.40 dividend. The ex-dividend date is Tuesday, June 4th. This represents a $5.60 annualized dividend and a yield of 1.64%. The Cigna Group’s payout ratio is 45.98%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the company. Morgan Stanley restated an “overweight” rating and issued a $392.00 target price (up previously from $382.00) on shares of The Cigna Group in a research report on Monday, March 4th. Royal Bank of Canada upgraded The Cigna Group from a “sector perform” rating to an “outperform” rating and lifted their price objective for the stock from $327.00 to $354.00 in a report on Monday, February 5th. Barclays assumed coverage on The Cigna Group in a report on Wednesday, March 6th. They set an “overweight” rating and a $393.00 target price for the company. Cantor Fitzgerald lifted their price target on The Cigna Group from $384.00 to $400.00 and gave the stock an “overweight” rating in a research note on Friday. Finally, Mizuho raised their target price on shares of The Cigna Group from $360.00 to $370.00 and gave the stock a “buy” rating in a report on Monday, February 5th. Two equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $366.14.

Insiders Place Their Bets

In other news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the firm’s stock in a transaction on Wednesday, February 7th. The stock was sold at an average price of $330.48, for a total value of $1,608,446.16. Following the transaction, the senior vice president now directly owns 2,102 shares in the company, valued at approximately $694,668.96. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In other news, insider Eric P. Palmer sold 1,017 shares of the firm’s stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $335.26, for a total value of $340,959.42. Following the transaction, the insider now owns 45,564 shares of the company’s stock, valued at $15,275,786.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the business’s stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $330.48, for a total value of $1,608,446.16. Following the transaction, the senior vice president now owns 2,102 shares of the company’s stock, valued at $694,668.96. The disclosure for this sale can be found here. In the last 90 days, insiders sold 114,144 shares of company stock valued at $39,296,330. 0.60% of the stock is owned by insiders.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.